DZ Bank’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.43B | Sell |
2,914,918
-616,675
| -17% | -$335M | 1.27% | 17 |
|
|
2025
Q4 | $2.05B | Buy |
3,531,593
+1,027,509
| +41% | +$581M | 1.77% | 9 |
|
|
2025
Q3 | $1.21B | Buy |
2,504,084
+1,970,033
| +369% | +$917M | 1.06% | 24 |
|
|
2025
Q2 | $217M | Sell |
534,051
-1,589,589
| -75% | -$665M | 0.22% | 93 |
|
|
2025
Q1 | $1.06B | Buy |
2,123,640
+588,497
| +38% | +$319M | 1.18% | 18 |
|
|
2024
Q4 | $799M | Sell |
1,535,143
-159,095
| -9% | -$87.5M | 0.81% | 32 |
|
|
2024
Q3 | $1.05B | Sell |
1,694,238
-466,518
| -22% | -$276M | 1.03% | 27 |
|
|
2024
Q2 | $1.19B | Sell |
2,160,756
-27,824
| -1% | -$15.9M | 1.22% | 16 |
|
|
2024
Q1 | $1.27B | Buy |
2,188,580
+543,918
| +33% | +$305M | 1.36% | 16 |
|
|
2023
Q4 | $873M | Sell |
1,644,662
-865,916
| -34% | -$419M | 1.09% | 24 |
|
|
2023
Q3 | $1.27B | Buy |
2,510,578
+1,417,175
| +130% | +$755M | 1.81% | 12 |
|
|
2023
Q2 | $570M | Sell |
1,093,403
-777,769
| -42% | -$420M | 0.86% | 28 |
|
|
2023
Q1 | $1.08B | Sell |
1,871,172
-31,313
| -2% | -$17.6M | 1.77% | 9 |
|
|
2022
Q4 | $1.05B | Sell |
1,902,485
-101,409
| -5% | -$53.7M | 1.82% | 11 |
|
|
2022
Q3 | $1.02B | Sell |
2,003,894
-16,232
| -0.8% | -$9.08M | 1.92% | 9 |
|
|
2022
Q2 | $1.1B | Buy |
2,020,126
+1,263,441
| +167% | +$695M | 1.98% | 7 |
|
|
2022
Q1 | $447M | Sell |
756,685
-95,404
| -11% | -$54.8M | 0.67% | 44 |
|
|
2021
Q4 | $567M | Sell |
852,089
-40,130
| -4% | -$25.1M | 0.8% | 40 |
|
|
2021
Q3 | $510M | Buy |
892,219
+22,447
| +3% | +$12.3M | 0.81% | 38 |
|
|
2021
Q2 | $439M | Sell |
869,772
-14,674
| -2% | -$6.92M | 0.71% | 43 |
|
|
2021
Q1 | $404M | Sell |
884,446
-387,174
| -30% | -$185M | 0.74% | 39 |
|
|
2020
Q4 | $587M | Sell |
1,271,620
-545,737
| -30% | -$256M | 1.24% | 17 |
|
|
2020
Q3 | $802M | Buy |
1,817,357
+302,047
| +20% | +$125M | 1.92% | 9 |
|
|
2020
Q2 | $549M | Buy |
1,515,310
+323,986
| +27% | +$109M | 1.51% | 12 |
|
|
2020
Q1 | $338M | Sell |
1,191,324
-91,943
| -7% | -$29M | 1.14% | 18 |
|
|
2019
Q4 | $417M | Buy |
1,283,267
+48,810
| +4% | +$14.8M | 1.09% | 21 |
|
|
2019
Q3 | $360M | Sell |
1,234,457
-106,204
| -8% | -$30.4M | 1.07% | 20 |
|
|
2019
Q2 | $394M | Sell |
1,340,661
-406,862
| -23% | -$112M | 1.22% | 19 |
|
|
2019
Q1 | $478M | Buy |
1,747,523
+104,753
| +6% | +$26.1M | 1.55% | 14 |
|
|
2018
Q4 | $365M | Sell |
1,642,770
-250,762
| -13% | -$58.8M | 1.42% | 15 |
|
|
2018
Q3 | $462M | Buy |
1,893,532
+19,986
| +1% | +$4.6M | 1.64% | 8 |
|
|
2018
Q2 | $388M | Buy |
1,873,546
+71,666
| +4% | +$15.2M | 1.43% | 10 |
|
|
2018
Q1 | $365M | Sell |
1,801,880
-38,470
| -2% | -$8.07M | 1.41% | 10 |
|
|
2017
Q4 | $349M | Buy |
1,840,350
+193,523
| +12% | +$37.1M | 1.34% | 14 |
|
|
2017
Q3 | $312M | Buy |
1,646,827
+594,069
| +56% | +$108M | 1.29% | 15 |
|
|
2017
Q2 | $184M | Buy |
1,052,758
+9,524
| +0.9% | +$1.6M | 0.85% | 36 |
|
|
2017
Q1 | $160M | Buy |
1,043,234
+283,163
| +37% | +$43.3M | 0.73% | 44 |
|
|
2016
Q4 | $107M | Buy |
+760,071
| New | +$112M | 0.52% | 58 |
|
Other funds holding TMO
VCM
DZ Bank's TMO Position: Q1 2026 in Review
DZ Bank reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q1 2026, selling an estimated $335M and leaving 2,914,918 shares worth $1.43B. The position accounts for 1.27% of the portfolio, ranked #17.
DZ Bank first reported a position in TMO in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.05B in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- DZ Bank held 2,914,918 shares of Thermo Fisher Scientific worth $1.43B as of Q1 2026.
- DZ Bank sold 616,675 Thermo Fisher Scientific shares in Q1 2026, an estimated $335M.
- Thermo Fisher Scientific made up 1.27% of DZ Bank's portfolio in Q1 2026, its #17 holding.
- DZ Bank first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 38 quarters since.
- DZ Bank's Thermo Fisher Scientific position peaked at $2.05B in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.